Antimutagenicity protection of Ginkgo biloba extract (Egb 761) against mitomycin C and cyclophosphamide in mouse bone marrow

Genetics and Molecular Research

Volumn 8, Issue 1, 2009, Pages 328-333

  Vilar, J B ^a   Leite, K R ^a   Chen Chen, L ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Antimutagenicity; Cyclophosphamide; Egb 761; Ginkgo biloba; Micronucleus test; Mitomycin c

Indexed keywords

CYCLOPHOSPHAMIDE; GINKGO BILOBA EXTRACT; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ERYTHROCYTE; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN;

ANIMALS; ANTIMUTAGENIC AGENTS; BONE MARROW; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICRONUCLEUS TESTS; MITOMYCIN; MUTAGENS; PLANT EXTRACTS;

GINKGO BILOBA; MUS;

EID: 66749094811     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol8-1gmr519     Document Type: Article

References (28)

1. Budzinski JW, Foster BC, Vandenhoek S and Arnason JT (2000). An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282.
2. Chen B, Cai J, Song LS, Wang X, et al. (2005). Effects of Ginkgo biloba extract on cation currents in rat ventricular myocytes. Life Sci. 76: 1111-1121.
3. De Flora S (1998). Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402: 151-158.
4. De Flora S and Ramel C (1988). Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat. Res. 202: 285-306.
5. De Flora S, Bennicelli C, Rovida A, Scatolini L, et al. (1994). Inhibition of the 'spontaneous' mutagenicity in Salmonella typhimurium TA102 and TA104. Mutat. Res. 307: 157-167.
6. De Flora S, Izzotti A, D'Agostini F, Balansky RM, et al. (2001). Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat. Res. 480-481: 9-22.
7. Ergun U, Yurtcu E and Ergun MA (2005). Protective effect of Ginkgo biloba against gossypol-induced apoptosis in human lymphocytes. Cell Biol. Int. 29: 717-720.
8. Gaudineau C, Beckerman R, Welbourn S and Auclair K (2004). Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem. Biophys. Res. Commun. 318: 1072-1078.
9. Goh LM and Barlow PJ (2002). Antioxidant capacity in Ginkgo biloba. Food Res. Int. 35: 815-820.
10. Huynh HT and Teel RW (2002). Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity. Anticancer Res. 22: 1699-1703.
11. Izzo AA and Ernst E (2001). Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175.
12. Kang YH, Lee KA, Ryu CJ, Lee HG, et al. (2006). Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Cancer Lett. 237: 33-44.
13. Kaur S, Arora S, Kaur K and Kumar S (2002). The in vitro antimutagenic activity of Triphala - an Indian herbal drug. Food Chem. Toxicol. 40: 527-534.
14. Krizkova L, Chovanova Z, Durackova Z and Krajcovic J (2008). Antimutagenic in vitro activity of plant polyphenols:Pycnogenol and Ginkgo biloba extract (EGb 761). Phytother. Res. 22: 384-388.
15. Kuilman ME, Maas RF and Fink-Gremmels J (2000). Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B(1) in bovine hepatocytes. Toxicol. In Vitro 14: 321-327.
16. Lautraite S, Musonda AC, Doehmer J, Edwards GO, et al. (2002). Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis 17: 45-53.
17. Le Bars PL, Katz MM, Berman N, Itil TM, et al. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278: 1327-1332.
18. LeBlanc GA and Waxman DJ (1990). Mechanisms of cyclophosphamide action on hepatic P-450 expression. Cancer Res. 50: 5720-5726.
19. Nunes WB (2004). Avaliacao do Potencial Genotoxico e/ou Antigenotoxico do Extrato Egb 761 de Ginkgo biloba, em Celulas Somaticas de Drosophila melanogaster Tratadas com Doxorrubicina. Doctoral thesis, Universidade Federal de Uberlandia, Uberlandia.
20. Qualls CW Jr, Lubet RA, Lochmiller RL, Elangbam CS, et al. (1998). Cytochrome P450 induction in feral Cricetid rodents: a review of field and laboratory investigations. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 121: 55-63.
21. Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, et al. (2002). Plants and human health in the twenty-first century. Trends Biotechnol. 20: 522-531.
22. Salamone M, Heddle J, Stuart E and Katz M (1980). Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene. Mutat. Res. 74: 347-356.
23. Schmid W (1975). The micronucleus test. Mutat. Res. 31: 9-15.
24. Shinozuka K, Umegaki K, Kubota Y, Tanaka N, et al. (2002). Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci. 70:2783-2792.
25. Tewey KM, Rowe TC, Yang L, Halligan BD, et al. (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468.
26. Vaes LP and Chyka PA (2000). Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann. Pharmacother. 34: 1478-1482.
27. Waters MD, Stack HF, Jackson MA, Brockman HE, et al. (1996). Activity profiles of antimutagens: in vitro and in vivo data. Mutat. Res. 350: 109-129.
28. Williamson EM (2001). Synergy and other interactions in phytomedicines. Phytomedicine 8: 401-409.